Galbraith N S, Crosby G, Barnes J M, Fernandes R
Br Med J. 1971 Apr 24;2(5755):193-7. doi: 10.1136/bmj.2.5755.193.
The simultaneous administration of B.C.G. vaccine, diphtheria-tetanus toxoid aluminium hydroxide adsorbed vaccine, and oral poliovaccine was studied in 628 children aged 13-14 years between 1966 and 1969 in Newham, London. The efficacy of these vaccines was unaffected by administering them at the same time; routine simultaneous administration is considered justified when organizational difficulties prevent the attainment of high immunization rates with the vaccines given separately. No adverse reactions to B.C.G. or oral poliomyelitis vaccines took place, but 8% of children had moderately severe local reactions after diphtheria-tetanus aluminium hydroxide adsorbed vaccine, which were attributed to diphtheria toxoid.Serological studies showed the need for immunization against diphtheria, tetanus, and poliomyelitis at 13-14 years of age. Because of the adverse reactions to diphtheria toxoid, however, simultaneous administration of tetanus toxoid aluminium hydroxide adsorbed, oral poliomyelitis, and B.C.G. vaccines only is recommended at present.An "adult type" diphtheria-tetanus toxoid might overcome the problem of reactions, though in two to three years' time most children aged 13-14 years will have received diphtheria-tetanus-pertussis vaccine in infancy and reinforcement might then be accomplished by a small intradermal dose of the currently available fluid diphtheria-tetanus vaccine.Continued serological studies of diphtheria and tetanus antitoxins and polio antibody are necessary to determine the future need for reinforcement of immunity; such studies should become an essential part of the surveillance of the community immunization programme.
1966年至1969年期间,在伦敦纽汉姆对628名13至14岁的儿童进行了卡介苗、吸附白喉-破伤风类毒素氢氧化铝疫苗和口服脊髓灰质炎疫苗同时接种的研究。这些疫苗同时接种时其效力不受影响;当组织上的困难妨碍分别接种疫苗达到高免疫率时,常规同时接种被认为是合理的。未发生对卡介苗或口服脊髓灰质炎疫苗的不良反应,但8%的儿童在接种吸附白喉-破伤风氢氧化铝疫苗后出现中度严重的局部反应,这些反应归因于白喉类毒素。血清学研究表明13至14岁儿童有必要接种白喉、破伤风和脊髓灰质炎疫苗。然而,由于对白喉类毒素有不良反应,目前仅建议同时接种吸附破伤风类毒素氢氧化铝疫苗、口服脊髓灰质炎疫苗和卡介苗。一种“成人型”白喉-破伤风类毒素可能会解决反应问题,不过再过两到三年,大多数13至14岁的儿童在婴儿期已接种白喉-破伤风-百日咳疫苗,届时可通过皮内注射小剂量目前可用的液体白喉-破伤风疫苗来加强免疫。对白喉和破伤风抗毒素以及脊髓灰质炎抗体进行持续的血清学研究对于确定未来加强免疫的必要性是必要的;此类研究应成为社区免疫规划监测的重要组成部分。